RA Capital Healthcare Fund LP, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 79,452 shares at $15.99 ($1.4M) on 2016-02-22, disclosed to the SEC on 2016-02-24.
Open-market purchase of $1.4M ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.99 | 11,318 | $181K | 13.3% |
| 2 | $15.99 | 11,318 | $181K | 13.3% |
| 3 | $17.62 | 28,408 | $501K | 36.7% |
| 4 | $17.62 | 28,408 | $501K | 36.7% |
| Total | $17.16 avg | 79,452 | $1.4M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |